Last reviewed · How we verify
An Investigator-Initiated Multicenter Prospective Clinical Trial to Examine the Efficacy of Peri-operative NSAID vs Steroid Treatment in Trabeculectomy Wound Management
This study will examine the efficacy of steroid vs NSAID treatment in relation to trabeculectomy wound management. Eligible study participants will be randomized to receive either steroid or NSAID topical treatment one week post-trabeculectomy. Each group will dose with their assigned study treatment until three months post-trabeculectomy. Study participants will be followed for twelve months post-trabeculectomy.
Details
| Lead sponsor | Cindy Hutnik |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 150 |
| Start date | 2020-11 |
| Completion | 2021-12 |
Conditions
- Glaucoma
Interventions
- Bromfenac 0.07% Oph Susp
- Dexamethasone
Primary outcomes
- Target IOP — 12 months
the proportion of patients achieving a target IOP range (≤21, ≤18, ≤15 or ≤12 mmHg) at 12 months post-operatively